Milu Labs

Milu Labs is a medical diagnostics company specializing in innovative technologies for screening and detecting health conditions, with a particular emphasis on maternal-fetal medicine and women's health. Headquartered in New York and with an office in Singapore, the company aims to be a leader in the Asian diagnostics market. Milu Labs develops cutting-edge diagnostic tools that leverage exosome fluid analysis and multi-omics approaches, including proteome, transcriptome, epigenome, and microbiome analysis. These technologies enable healthcare professionals to identify various women's health issues and facilitate early cancer detection. The company collaborates with global academic institutions and prominent healthcare organizations to enhance the quality of care and improve health outcomes through advancements in diagnostic science.